Nasdaq

53 articles
The Motley FoolThe Motley Fool··Emma Newbery

Nasdaq Surges to Record Highs on AI Boom and Robust Jobs Data

Nasdaq surges 1.7% to record highs on strong jobs data and AI demand; Micron jumps 16%, while Cloudflare and HubSpot plunge on disappointing results.
RKLBNVDAMUHUBSINTC+1Nasdaqtech stocks
BenzingaBenzinga··Na

Cold-Pressed Juice Maker Suja Life Prices IPO at $21, Eyes $173.6M Raise

Suja Life prices IPO at $21 per share, raising ~$173.6M to fund debt repayment and parent acquisition. Trading begins May 7 on Nasdaq under ticker $SUJA.
JEFIPOdebt repayment
BenzingaBenzinga··Na

Hemab Therapeutics Prices $346.7M IPO as Blood Disorder Biotech Debuts on Nasdaq

Hemab Therapeutics raised $346.7M in upsized IPO, pricing 19.3M shares at $18 with full underwriter exercise.
COAGIPOclinical-stage
The Motley FoolThe Motley Fool··Emma Newbery

Tech Surge Powers S&P 500, Nasdaq to Record Highs Despite Oil Shock

S&P 500 and Nasdaq hit record highs May 1 on strong tech earnings, with 80% of companies beating estimates. Oil spiked above $106/barrel, signaling macro headwinds.
SNDKMUAAPLXOMCVX+5S&P 500earnings beat
BenzingaBenzinga··Tanya Rawat

Larry Page Joins $300B Club as AI Rally Lifts World's Richest to $2.7T

Larry Page's net worth hit $313 billion in April 2026 AI rally, becoming only third person to surpass $300B milestone. Elon Musk remains world's richest.
WMTMETAMSFTAMZNGOOG+1S&P 500Nasdaq
Investing.comInvesting.com··Fiona Cincotta

US Stocks Post Best Month Since 2024 as Geopolitical Fears Ease

US stocks delivered strongest monthly gains in years during April, with S&P 500 up 10%, Nasdaq 15%, and Dow 7%, driven by Middle East ceasefire optimism and solid earnings, though Fed policy concerns and seasonal weakness loom.
AAPLXOMCVXFederal ReserveS&P 500
BenzingaBenzinga··Sweta Killa

Seaport Therapeutics Eyes Nasdaq Debut With $255M IPO, Signaling Biotech Sector Momentum

Seaport Therapeutics raised $255 million through IPO priced at $18/share, beginning Nasdaq trading Friday as ticker $SPTX, amid growing biotech IPO momentum.
SFTBYAVEXXEIPObiotech
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Hemab Therapeutics Prices $301.5M IPO at $18/Share, Nasdaq Debut Set for May

Hemab Therapeutics prices $301.5M IPO at $18/share, listing on Nasdaq as $COAG starting May 1, 2026.
JEFEVRIPOclinical-stage
GlobeNewswire Inc.GlobeNewswire Inc.··Na

U-BX Technology Raises $4.55M via Direct Offering to Fund InsurTech Growth

U-BX Technology closes $4.55M registered direct offering, selling 15.17M units at $0.30 each to fund AI-driven insurtech growth and development.
UBXGartificial intelligencecapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Globe Newswire

Churchill Capital Corp XII Prices $360M SPAC IPO, Targets Nasdaq Listing

Michael Klein's Churchill Capital Corp XII prices $360M blank-check IPO at $10 per unit on Nasdaq, with April 2026 closing expected.
CCpNCpRIPOSPAC
The Motley FoolThe Motley Fool··Adria Cimino

Nasdaq Surges Toward Records as AI Stock Valuations Normalize

Nasdaq rebounds to all-time highs as AI stocks recover from recent selloffs, offering investors potentially attractive entry points after valuations normalize.
NVDATSMPLTRAI stocksNasdaq
The Motley FoolThe Motley Fool··Keithen Drury

AI Stock Rally Continues: Analysts See Upside Despite Recent Gains

AI stocks rally continues with Microsoft at 20% discount and Nvidia, Broadcom poised for potential doubling amid accelerating chip demand.
NVDAMSFTAVGOvaluationNasdaq
GlobeNewswire Inc.GlobeNewswire Inc.··Na

ArrowMark Financial Corp. NAV Holds Steady at $21.12 Amid Banking Sector Shifts

ArrowMark Financial Corp. ($BANX) reports March 2026 NAV of $21.12, continuing its focus on generating shareholder income through regulatory capital securities of financial institutions.
BANXRISENasdaqclosed-end fund
The Motley FoolThe Motley Fool··Emma Newbery

S&P 500, Nasdaq Hit Record Highs as Tech Surge Overshadows Dow Weakness

S&P 500 and Nasdaq hit records as Intel surges 23% on earnings; semiconductor sector extends 18-day winning streak amid AI rally.
NVDAMETAMSFTINTCearningssemiconductor stocks
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

MoneyFlare's AI Trading Bot Enters Crowded Market as Equities Hit Record Peaks

MoneyFlare launches AI stock trading bot for retail investors as S&P 500 and Nasdaq hit record highs, emphasizing automated execution and risk management.
SCHWSCHWpDSCHWpJfintechS&P 500
The Motley FoolThe Motley Fool··Dave Kovaleski

Wall Street's AI Darlings: Applied Digital and Nvidia Offer Growth at Reasonable Valuations

Analysts favor $APLD and $NVDA for AI exposure. Applied Digital expanding data centers; Nvidia trading at 24x forward P/E with strong earnings growth.
NVDACRWVORCLORCLpDAPLDdata centersartificial intelligence
BenzingaBenzinga··Not Specified

OIO Group Completes De Tomaso Merger, Shifts Control to Founder Choi

OIO Group completes De Tomaso merger; De Tomaso founder Norman Choi becomes controlling shareholder, CEO, and Chairman. 1-for-3 reverse split effective April 24, 2026.
OIOOIOWWNasdaqbusiness combination
The Motley FoolThe Motley Fool··Harsh Chauhan

AMD Positioned as Nasdaq's Top Performer in 2026 as AI Chip Demand Accelerates

AMD positioned as top Nasdaq performer in 2026 with 60%+ data center growth and MI450 GPU launch driving 60% earnings growth versus market's 18%.
NVDAAMDMETAAI chipsearnings growth
The Motley FoolThe Motley Fool··Geoffrey Seiler

Nasdaq's AI Rally Gains Momentum as Investors Pivot to Growth Leaders

Nasdaq AI rally accelerates as investors return to growth stocks. Alphabet and Amazon leverage AI infrastructure and custom chips to dominate the opportunity.
AMZNGOOGGOOGLagentic AIcloud computing
BenzingaBenzinga··Na

Kailera Raises $718.8M in IPO as Obesity Care Biotech Enters Public Markets

Kailera Therapeutics raises $718.8M in IPO at $16/share as obesity care biotech enters public markets with strong underwriter demand.
KLRAIPOcapital raising